pyridostigmine bromide has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loures, DL; Mesquita, ET; Nobrega, AC; Pontes, PV; Sant'anna, ID | 1 |
| Das, MK; Dusa, AC; Otten, RF | 1 |
1 trial(s) available for pyridostigmine bromide and Coronary Artery Disease
| Article | Year |
|---|---|
Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients.
Topics: Cholinesterase Inhibitors; Coronary Artery Disease; Cross-Over Studies; Diastole; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyridostigmine Bromide; Stress, Psychological; Stroke Volume; Ventricular Dysfunction | 2008 |
1 other study(ies) available for pyridostigmine bromide and Coronary Artery Disease
| Article | Year |
|---|---|
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy.
Topics: Anti-Arrhythmia Agents; Atropine; Brugada Syndrome; Cardiotonic Agents; Cholinesterase Inhibitors; Coronary Artery Disease; Diagnosis, Differential; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Pedigree; Procainamide; Pyridostigmine Bromide | 2007 |